Perspectives on Sickle Cell Disease: Unique Clinical Needs for a Comprehensive, Coordinated Approach to Disease Management

Program Description

Life-threatening complications of sickle cell disease (SCD) can result in repeat hospitalizations, missed school or workdays, and generally poor quality of life for patients. SCD is a multisystem disorder, and the variations of SCD manifest in different degrees of severity requiring different types of treatments. The 2 hallmark symptoms of SCD are hemolytic anemia and vaso-occlusion. These symptoms can be painful, and each contributes to increased health care resource utilization. Consequently, both adults and pediatric patients living with SCD may require pain management therapy as well as need for acute treatment options with therapies targeted to treat SCD and vaso-occlusive crises. This webinar will review emerging treatments for SCD including innovative approaches with the potential for long-term disease control for patients with SCD. Strategies for managed care professionals to ensure continuity of care as patients with SCD transition from adolescence to adulthood will be presented along with guideline-recommended standards of care in SCD treatment.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: January 31, 2023
Expiration date: January 31, 2024

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Investigate the clinical manifestations, common comorbidities, and the unpredictability of symptoms associated with sickle cell disease (SCD)
• Examine the clinical practice guidelines and standards of care for the diagnosis and treatment of SCD
• Analyze the clinical trial and real-world data for available pharmacotherapies, the advances in emerging agents, and future directions in the treatment of SCD

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-23-019-H01-P. The activity is available for CE credit through January 31, 2024.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Lindsey Dayer, PharmD, BCACP

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Abigail Dill; Susan Pordon; Brianna Winters; and Chloe Taccetta.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms